Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosis

Data from controlled clinical studies in patients with more advanced idiopathic pulmonary fibrosis (IPF) could inform clinical practice, but they are limited, since this sub-population is usually excluded from clinical trials. These exploratory post-hoc analyses of the open-label, long-term extensio...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Respir Res
Main Authors: Costabel, Ulrich, Albera, Carlo, Glassberg, Marilyn K., Lancaster, Lisa H., Wuyts, Wim A., Petzinger, Ute, Gilberg, Frank, Kirchgaessler, Klaus-Uwe, Noble, Paul W.
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2019
Assuntos:
Letter to the Editor
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6416878/
https://ncbi.nlm.nih.gov/pubmed/30866942
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-019-1021-2
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares